Trastuzumab and sepsis Patient Reports February 10, 2010

Trastuzumab Side Effects Report #5724013-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Apr 17, 2008. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis . Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5779498-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on June 04, 2008. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis , venous thrombosis. Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5821958-X
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on July 11, 2008. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis , venous thrombosis. Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #6092787-X
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 10, 2009. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis , venous thrombosis. Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.


Trastuzumab Side Effects Report #5386864-6
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 29, 2007. Female patient, weighting 180.8 lb, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lymphocyte percentage decreased, neutrophil percentage increased, pneumonia , pyrexia, sepsis . Trastuzumab dosage: 4 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, DICLOFENAC, METOPROLOL SUCCINATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, CEFUROXIME, THIAMAZOLE. Patient was hospitalized. Patient died.